Table 1.
Suggested initiation/monitoring studies for patients receiving a TKI for treatment of thyroid cancer
| Baseline studies/imaging (monthly for the first 3 months, then every 2–3 months) | ||
|---|---|---|
| CBC | Calcium | PT/PTT |
| Electrolytes | Magnesium | INR |
| BUN | Phosphorous | TSH/Free T4 |
| Creatinine | Albumin | Urinalysis |
| Glucose | AST (SGPT)/ALT (SGOT) | B HCG (for women of childbearing potential) |
| T Bilirubin | LDH | Electrocardiogram |